STRM.BIO | RoundOS

Weekly digest by email

Loading companies…

STRM.BIO | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jan 7, 2026	Seed2	$8M	Blue Bay Capital Fund — Role not disclosedBoehringer Ingelheim Ventures — Role not disclosedDelos Capital — Role not disclosedRecordati — Role not disclosed

Investors

Blue Bay Capital FundSeed2 Boehringer Ingelheim VenturesSeed2 Delos CapitalSeed2 RecordatiSeed2

Coverage

Jan 7, 2026STRM.BIO · Seed2

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

TransfyrPhysical AI platform capturing real-world lab science into machine-readable data$25M · Seed

Sources